ResMed Inc.
RSMDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $40,093,781 | $37,789,776 | $32,843,048 | $33,585,642 |
| - Cash | $1,383,848 | $1,209,450 | $932,711 | $521,944 |
| + Debt | $846,352 | $851,813 | $839,772 | $839,736 |
| Enterprise Value | $39,556,285 | $37,432,139 | $32,750,109 | $33,903,434 |
| Revenue | $1,335,582 | $1,347,993 | $1,291,736 | $1,282,089 |
| % Growth | -0.9% | 4.4% | 0.8% | – |
| Gross Profit | $820,820 | $820,070 | $766,408 | $751,275 |
| % Margin | 61.5% | 60.8% | 59.3% | 58.6% |
| EBITDA | $503,284 | $532,341 | $469,603 | $479,012 |
| % Margin | 37.7% | 39.5% | 36.4% | 37.4% |
| Net Income | $348,536 | $379,705 | $365,041 | $344,622 |
| % Margin | 26.1% | 28.2% | 28.3% | 26.9% |
| EPS Diluted | 2.37 | 2.58 | 2.48 | 2.34 |
| % Growth | -8.1% | 4% | 6% | – |
| Operating Cash Flow | $457,321 | $538,766 | $578,661 | $308,623 |
| Capital Expenditures | -$42,965 | -$30,585 | -$23,788 | -$18,877 |
| Free Cash Flow | $414,356 | $508,181 | $554,873 | $289,746 |